Compared with people who rarely took the stairs, regular stair climbers were 39 percent less likely to die from cardiovascular disease and 24 percent less likely to die from any cause. The study also ...

Repatha (evolocumab) lowered the risk of death from any cause by 20% in high-risk adults without a previous heart attack or ...

Among cause-specific cardiovascular deaths, evolocumab showed directionally favorable effects for acute MI, stroke, and heart ...

The FDA has approved Mounjaro to reduce cardiovascular risk in people with type 2 diabetes after a major trial found it ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide, liraglutide, and tirzepatide are widely prescribed both for Type 2 diabetes and weight loss. These drugs also have shown ...

A clinical trial in which cardiac patients received intravenous dexrazoxane before, during and after their blocked coronary ...

Diabetes may independently raise the risk for sudden cardiac death, regardless of obstructive coronary artery disease status.

Heart disease still kills more Americans than any other single cause, and the vast majority of those deaths are tied to risk factors that individuals and health systems can act on. Provisional 2023 ...

Following a five-year upward trend likely impacted by the COVID pandemic, the number of heart disease and stroke deaths has declined, yet, heart disease and stroke still kill more people in the U.S.

Share on Pinterest New research shows that choosing to take the stairs could help reduce your risk of heart disease and early death. baona · E+/Getty A major study has recently found that taking the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...